| Title |
Sulfasalazine for ankylosing spondylitis
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, April 2005
|
| DOI | 10.1002/14651858.cd004800.pub2 |
| Pubmed ID | |
| Authors |
Chen, Junmin, Liu, Chao |
| Abstract |
Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown cause and belongs to a group of diseases known as spondyloarthropathies (SpA), which includes reactive arthritis, arthritis/spondylitis in inflammatory bowel disease, psoriatic arthritis/spondylitis and undifferentiated SpA. Non-steroidal anti-inflammatory drugs (NSAIDs) have been the main treatment for AS. For those refractory or intolerant to NSAIDs, the disease modifying antirheumatic drugs (DMARDs) have been used as a second line approach. Sulfasalazine (SSZ) is the best studied DMARD in AS, but its efficacy remains unclear. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | 3% |
| Brazil | 1 | 2% |
| Finland | 1 | 2% |
| Canada | 1 | 2% |
| Guatemala | 1 | 2% |
| Unknown | 59 | 91% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 13 | 20% |
| Researcher | 7 | 11% |
| Student > Postgraduate | 6 | 9% |
| Student > Doctoral Student | 6 | 9% |
| Other | 5 | 8% |
| Other | 14 | 22% |
| Unknown | 14 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 46% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
| Engineering | 3 | 5% |
| Agricultural and Biological Sciences | 3 | 5% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Other | 9 | 14% |
| Unknown | 15 | 23% |